The Australian Government is now in caretaker period. During this time, updates on this website will be published in accordance with the Guidance on Caretaker Conventions, until after the election.
NHMRC opened a Targeted Call for Research (TCR) into Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) on 23 October 2019. Applications closed on 29 January 2020.
The development of this TCR was guided by the Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) Advisory Committee established by the NHMRC.
The intended aims of this TCR were to:
- Develop a scientifically valid, evidence-based understanding of the pathophysiology and aetiology of ME/CFS and the way it impacts on the physical, social and psychological wellbeing of affected persons.
- Identify approaches that will assist patients presenting with symptoms of ME/CFS to be accurately diagnosed, including the identification potential biomarkers to facilitate effective management and treatment.
- Cultivate interdisciplinary research collaboration, both locally and internationally.
Applications received during the call were peer reviewed by an expert panel. Following peer review, 3 applications were funded by NHMRC. Details of the awarded grants are provided in the Funding outcomes table.
App ID | Chief Investigator A | Application Title | Administering Institution | Budget | Grant duration |
---|---|---|---|---|---|
APP1199363 | Professor Ken Walder | Using ‘omics to unravel the pathophysiology and repurpose drugs to treat ME/CFS | Deakin University | $1,083,010.00 | 2020-2025 |
APP1199502 | Professor Sonya Marshall-Gradisnik | Ion channel dysfunction in the pathophysiology of Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: diagnostic biomarkers, therapeutic targets and treatments | Griffith University | $1,460,700.00 | 2021-2025 |
APP1200292 | Professor Paul Gooley | Exploring the role of nitrogen metabolism, energy metabolism and mitochondrial function in the pathophysiological mechanisms of paediatric ME/CFS | University of Melbourne | $784,063.50 | 2020-2023 |